What is viscosupplementation?

Viscosupplementation is a medical procedure involving the injection of a gel-like fluid containing hyaluronic acid derivatives directly into the knee joints. This fluid acts as a lubricant, reducing friction, inflammation, and pain, while also cushioning joint loads.

How big is the Viscosupplementation Market?

The global Viscosupplementation Market size was estimated at USD 3,562.9 Million in 2023 and is expected to reach USD 7,763.6 Million in 2033.

What is the Viscosupplementation Market growth?

The global Viscosupplementation Market is expected to grow at a compound annual growth rate of 8.1%. From 2024 To 2033

Who are the key companies/players in the Viscosupplementation Market?

Some of the key players in the Viscosupplementation Markets are Sanofi S.A., Anika Therapeutics, Inc., Seikagaku Corp., Zimmer Biomet, Smith & Nephew PLC, Ferring Pharmaceuticals B.V., Lifecore Biomedical, LG Life Sciences Ltd., Fidia Farmaceutici S.p.A, Hoffmann-La Roche Ltd., Other Key Players.

What are the benefits of viscosupplementation?

Viscosupplementation offers comprehensive benefits, including smoother bone movement, reduced inflammation, alleviation of severe pain, improved joint range of motion, and chondroprotective effects. It also restores the rheological properties of synovial fluids.

What conditions does viscosupplementation treat?

Viscosupplementation is primarily used to treat osteoarthritis of the knee, but it can also be applied to osteoarthritis affecting the hip and hand joints.

Global Viscosupplementation Market, By Dosage (Single Injection, Three Injection, Five Injection) By Application (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, and Other Applications) By End-Users (Hospitals, Orthopedics Clinics, Ambulatory Surgical Centers, and Other End Users), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Feb 2024
Report ID: 104244
Number of Pages: 341
Format:

- Sanofi S.A.
- Anika Therapeutics, Inc.
- Seikagaku Corp.
- Zimmer Biomet
- Smith & Nephew PLC
- Ferring Pharmaceuticals B.V.
- Lifecore Biomedical
- LG Life Sciences Ltd.
- Fidia Farmaceutici S.p.A
- Hoffmann-La Roche Ltd.
- Other Key Players
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 104244
Published Date Feb 2024
Rating
- ★★★★★
  
  ★★★★★
- (114)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)